[Pharmacoeconomic evaluation of the tixagevimab and cilgavimab combination using for pre-exposure prophylaxis of COVID-19].
M V ZhuravlevaVladimir P ChulanovJ V GagarinaE A ShabalinaPublished in: Terapevticheskii arkhiv (2023)
Pre-exposure prophylaxis of COVID-19 with combination of tixagevimab and cilgavimab is economically feasible and may be recommended for wide use in Russian healthcare system.